Trial NCT05227131

View at ClinicalTrials.gov 
Org. Study IDs: MEDOPP447
Secondary IDs: 2021-006387-24

Last trial update was posted on 2022-07-11

MeSH Interventions

Capecitabine Margetuximab Tucatinib

MeSH Conditions

Breast Neoplasms

Other Conditions

Advanced Breast Cancer HER2-positive Breast Cancer Metastatic Breast Cancer

Stopping Reasons

Funder decided to not continue the study

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID